149 related articles for article (PubMed ID: 21961481)
1. Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity.
Wijeratne C; Draper B
Aust N Z J Psychiatry; 2011 Dec; 45(12):1026-32. PubMed ID: 21961481
[TBL] [Abstract][Full Text] [Related]
2. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
3. Use of antipsychotic drugs and lithium in mania.
Cookson J
Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
[TBL] [Abstract][Full Text] [Related]
4. Lithium in bipolar and other affective disorders: prescribing practice in the UK.
Paton C; Barnes TR; Shingleton-Smith A; McAllister-Williams RH; Kirkbride J; Jones PB; McIntyre S;
J Psychopharmacol; 2010 Dec; 24(12):1739-46. PubMed ID: 20488832
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of lithium in patients with bipolar affective disorder: experiences from a tertiary care hospital in India.
Sharma S; Joshi S; Chadda RK
Am J Ther; 2009; 16(5):393-7. PubMed ID: 19262359
[TBL] [Abstract][Full Text] [Related]
6. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
7. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
8. Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice.
Wilting I; Movig KL; Moolenaar M; Hekster YA; Brouwers JR; Heerdink ER; Nolen WA; Egberts AC
Bipolar Disord; 2005 Jun; 7(3):274-80. PubMed ID: 15898965
[TBL] [Abstract][Full Text] [Related]
9. Appropriateness of plasma level determinations for lithium and valproate in routine care of psychiatric inpatients with affective disorders.
Mann K; Hiemke C; Lotz J; Schmidt LG; Lackner KJ; Bates DW
J Clin Psychopharmacol; 2006 Dec; 26(6):671-3. PubMed ID: 17110832
[No Abstract] [Full Text] [Related]
10. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
11. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
12. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
Sachs GS; Printz DJ; Kahn DA; Carpenter D; Docherty JP
Postgrad Med; 2000 Apr; Spec No():1-104. PubMed ID: 10895797
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with pharmacologic noncompliance in patients with mania.
Keck PE; McElroy SL; Strakowski SM; Stanton SP; Kizer DL; Balistreri TM; Bennett JA; Tugrul KC; West SA
J Clin Psychiatry; 1996 Jul; 57(7):292-7. PubMed ID: 8666570
[TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
15. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
[TBL] [Abstract][Full Text] [Related]
16. Mania complicated with delirium following cessation of long-term lithium therapy.
Lin CE; Mao WC
Gen Hosp Psychiatry; 2010; 32(1):102-4. PubMed ID: 20114136
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
[TBL] [Abstract][Full Text] [Related]
18. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
19. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
